April Journal-2009.p65 - Association of Biotechnology and Pharmacy

Current Trends in Biotechnology and Pharmacy
Vol. 3 (2) 138-148, April 2009. ISSN 0973-8916
B.P. (2008). Butyrate-induced phosphatase
regulates VEGF and angiogenesis via Sp1.
Archives of Biochemistry and Biophysics,
478: 85-95.
28. Fotsis, T., Pepper, M.S., Aktas, E., Breit,
S., Rasku, S., Adlercreutz, H., Wahala, K.,
Montesano, R. and Schweigerer, L. (1997).
Flavonoids, dietary-derived inhibitors of cell
proliferation and in vitro angiogenesis.
Cancer Research, 57: 2916-2921.
29. Budhi-raja, R.D. and Sudhir, S. (1998).
Review of biological activity of
withanolides.Journal of Scientific and
Industrial Research, 46: 488-491.
30. Sethi, P.D., Thiagarajan, A.R. and
Subrahamanian, S.S. (1990). Studies on the
anti-inflammatory and anti-arthritic activity
of withaferin-A. Indian Journal of
Pharmacology, 12: 165-172.
31. Uma Devi, P., Sharada, A.C. and Solomon,
F.E. (1995). In vivo growth inhibitory and
radiosensitizing effects of withaferin A on
mouse Ehrlich ascites carcinoma. Cancer
Letters, 95:189-193.
32. Sadick, H., Naim, R., Gossler, U., Hormann,
K. and Riedel, F. (2005). Angiogenesis in
hereditary hemorrhagic telangiectasia:
VEGF165 plasma concentration in
correlation to the VEGF expression and
microvessel density. International Journal of
Molecular Medicine, 15:15-19.
33. Mesiano, S., Ferrara, N. and Jaffe, R.B.
(1998). Role of Vascular Endothelial Growth
Factor in Ovarian Cancer Inhibition of
Ascites Formation by Immunoneutralization.
American Journal of Pathology, 153:
1249-1256.
34. Kim, K.J., Li, B., Winer, J., Armanini, M.,
Gillett, N., Phillips, H.S. and Ferrara, N.
(1993). Inhibition of vascular endothelial
growth factor induced angiogenesis
148
suppresses tumor growth in-vivo. Nature,
362: 841-844.
35. Prabhakar, B.T., Khanum, S.A.,
Shashikanth, S. and Salimath, B.P. (2006).
Antiangiogenic effect of 2-benzoyl-phenoxy
acetamide in EAT cell is mediated by HIF-
1 á and down regulation of VEGF in vivo.
Investigation of New Drugs, 24: 471-478.
36. Oh, J.H., Lee, T.J., Kim, S.H., Choi, Y.H.,
Lee, S.H., Lee, J.M., Kim, Y.H., Park, J.W.
and Kwon, T.K. (2008). Induction of
apoptosis by withaferin A in human leukemia
U937 cells through down-regulation of Akt
phosphorylation.Apoptosis, 13:1494-504.
37. Oh, J.H., Lee, T.J., Park, J.W. and Kwon,
T.K. (2008). Withaferin A inhibits iNOS
expression and nitric oxide production by Akt
inactivation and down-regulating LPSinduced
activity of NF-kappaB in RAW
264.7 cells. European Journal of
Pharmacology, 599:11-7.
38. Divya, S., Amita, A., Rakesh, M. and Sita,
N. (2007). Withania somnifera inhibits NFêB
and AP-1 transcription factors in human
peripheral blood and synovial fluid
mononuclear cells.Phytotherapy Research,
21: 905-913.
39. Kaileh, M., Vanden, B.W., Heyerick, A.,
Horion, J., Piette, J., Libert, C., De
Keukeleire, D., Essawi, T. and Haegeman,
G. (2007). Withaferin A strongly elicits IêB
Kinase beta hyperphosphorylation
concomitant with potent inhibition of its
kinase activity. Journal of Biological
Chemistry, 282: 4253-4264.
40. Wei, D., Wang, L., He, Y., Henry James,
Q.X., Abbruzzese, L. and Xie, K. (2004).
Celecoxib Inhibits Vascular Endothelial
Growth Factor Expression in and Reduces
Angiogenesis and Metastasis of Human
Pancreatic Cancer via Suppression of Sp1
Transcription Factor Activity. Cancer
Research, 64:2030-2038.
Sp1 transcription factor